Federal Register / Vol. 65, No. 129 / Wednesday, July 5, 2000 / Notices 41471

involves numerous collaborations with

agencies such as MOHs, WHO, UNICEF,

and the World Bank. Domestically, as

the largest supplier of blood in the U.S.,

ARC is uniquely positioned to

collaborate with Federal agencies and

AIDS control program officials in blood

safety.

6. ARC has access to a wealth of HIV/

AIDS resources that may be adapted,

both from its domestic programs and its

international initiatives, such as the

ARCHI tool kits and the Federation’s

Action with Youth, HIV/AIDS STDs: A

Training Manual for Young People.

Additionally, ARC and the Federation

have expertise in establishing regional

networking mechanisms for

dissemination of information and

lessons learned. For example, the

‘‘Caribbean Youth HIV/AIDS Network’’

(CARAN) and the ‘‘Asian Red Cross /

Red Crescent Task Force on HIV/AIDS’’

(ART) are models that are being

replicated in West Africa.

7. ARC has already developed a range

of technical services domestically,

including instructor training courses,

communication and cooperation in

sharing Red Cross HIV/AIDS

information and resources on a

statewide basis in the U.S., support of

home care for people living with HIV/

AIDS, and prevention among youth

through peer-to-peer education

programs. Through the Federation, ARC

is uniquely positioned to disseminate

this information to national AIDS

control program officials in LIFE

countries.

Note: Public Law 104–65 states that an

organization described in section 501(c)(4) of

the Internal Revenue Code of 1986 that

engages in lobbying activities is not eligible

to receive Federal funds constituting an

award, grant, cooperative agreement,

contract, loan or any other form.

C. Availability of Funds

Approximately $3 million is available

in FY 2000 to support this award. It is

expected that the award will begin on or

about September 1, 2000, and will be

made for a 12-month budget period

within a project period of up to 3 years.

Funding estimates may change.

Continuation awards within an

approved project period will be made

on the basis of satisfactory progress as

evidenced by required reports and the

availability of funds.

Use of Funds

Funds received from this

announcement will not be used for the

purchase of antiretroviral drugs for

treatment of established HIV infection,

occupational exposures, and nonoccupational exposures and will not be

used for the purchase of machines and

reagents to conduct the necessary

laboratory monitoring for patient care.

Applicants may contract with other

organizations under these cooperative

agreements, however, applicants must

perform a substantial portion of the

activities (including program

management and operations and

delivery of prevention services for

which funds are requested).

D. Where To Obtain Additional

Information

This and other CDC announcements

can be found on the CDC home page

Internet address—http://www.cdc.gov.

Scroll down the page, then click on

‘‘Funding’’ then ‘‘Grants and

Cooperative Agreements.’’

To receive additional written

information and to request an

application kit, call 1–888–GRANTS4

(1–888–472–6874). You will be asked to

leave your name and address and will

be instructed to identify the

Announcement number of interest.

If you have questions after reviewing

the contents of all the documents,

business management technical

assistance may be obtained from:

Yolanda I. Gonzalez-Alvarez, Grants

Management Specialist, Centers for

Disease Control and Prevention (CDC),

Procurement and Grants Office, Room

3000, Mailstop E–15, 2920 Brandywine

Road, Atlanta, GA 30341–4146,

Telephone: (770) 488–2781, E-mail:

ybg0@cdc.gov.

For program technical assistance,

contact: Leo Weakland, Deputy

Coordinator, Global AIDS Activity

(GAA), National Center for HIV, STD,

and TB Prevention, Centers for Disease

Control and Prevention (CDC), 1600

Clifton Road, Mailstop E–07, Atlanta,

GA30333, Telephone number (404) 639–

8016, Email address: lfw0@cdc.gov.

Dated: June 28, 2000.

John L. Williams,

Director, Procurement and Grants Office,

Centers for Disease Control and Prevention

(CDC).

[FR Doc. 00–16850 Filed 7–3–00; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

The Centers for Disease Control and

Prevention (CDC)and the Agency for

Toxic Substances and Disease

Registry (ATDSR) Announces the

Following Meetings

Name: National HIV Prevention Plan

Meetings.

Time and Dates: 9 a.m.–12 p.m. (noon).

Tuesday—July 18, 2000

Hotel Pennsylvania, 401 7th Avenue, New

York, NY 10001, Phone: 212–736–5000

Wednesday—July 26, 2000

Crowne Plaza-Houston, 2222 West Loop

South, Houston, TX 77027, Phone: 713–

961–7272

Thursday—July 27, 2000

Congress Plaza Hotel, 520 South Michigan

Avenue, Chicago, IL 60605, Phone: 312–

427–3800

Tuesday—August 1, 2000

The Argent Hotel, 50 Third Street, San

Francisco, CA 94103, Phone: 415–974–

6400

Place: See Above.

Status: Open to the public, limited only by

the space available. The meeting room

accommodates approximately 100 people.

Purpose: To present the current draft of the

Centers for Disease Control and Prevention’s

National HIV Prevention Strategic Plan and

to provide an opportunity for community

comment.

Matters To Be Discussed: Agenda items

include background and development of the

draft National HIV Prevention Strategic Plan;

the plan itself; next steps in plan

development; and public comments.

Contact Person for More Information:

Lydia Ogden, National Center for HIV, STD,

and TB Prevention, Office of Planning and

Policy Coordination, 1600 Clifton Road, N.E.,

M/S E–07, Atlanta, Georgia 30333, telephone

404/639–8031.

The Director, Management Analysis and

Services Office, has been delegated the

authority to sign Federal Register Notices

pertaining to announcements of meetings and

other committee management activities, for

both the Centers for Disease Control and

Prevention and the Agency for Toxic

Substances and Disease Registry.

Dated: June 23, 2000.

Carolyn J. Russell,

Director, Management Analysis and Services

Office, Centers for Disease Control and

Prevention.

[FR Doc. 00–16846 Filed 7–3–00; 8:45 am]

BILLING CODE 4163–18–P